ammonium hydroxide has been researched along with conductase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbiati, R; Fici, F; Salerno, F | 1 |
| Abbiati, R; Conti, M; Fici, F; Lorenzini, MC; Salerno, F | 1 |
| Belvisi, A; Fici, F; Matergi, M | 1 |
1 trial(s) available for ammonium hydroxide and conductase
| Article | Year |
|---|---|
Effect of pyridoxine-2-oxoglutarate administration in patients with advanced cirrhosis: control of ammonia pyruvate and lactate high plasma concentrations.
Topics: Amino Acids; Ammonia; Blood Glucose; Clinical Trials as Topic; Double-Blind Method; Humans; Lactates; Lactic Acid; Liver Cirrhosis; Pyridoxine; Pyruvates; Pyruvic Acid; Random Allocation | 1982 |
2 other study(ies) available for ammonium hydroxide and conductase
| Article | Year |
|---|---|
Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis.
Topics: Aged; Amino Acids; Ammonia; Blood Glucose; Double-Blind Method; Drug Evaluation; Female; Humans; Lactates; Lactic Acid; Liver Cirrhosis; Male; Middle Aged; Pyridoxine; Pyruvates; Pyruvic Acid; Random Allocation | 1983 |
Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK).
Topics: Acidosis; Adult; Aged; Ammonia; Double-Blind Method; Female; Humans; Lactates; Lactic Acid; Liver Cirrhosis; Male; Middle Aged; Pyridoxine | 1982 |